Impairment of innate immune responses in cirrhotic patients and treatment by branched-chain amino acids

World J Gastroenterol. 2014 Jun 21;20(23):7298-305. doi: 10.3748/wjg.v20.i23.7298.

Abstract

It has been reported that host defense responses, such as phagocytic function of neutrophils and natural killer (NK) cell activity of lymphocytes, are impaired in cirrhotic patients. This review will concentrate on the impairment of innate immune responses in decompensated cirrhotic patients and the effect of the treatment by branched-chain amino acids (BCAA) on innate immune responses. We already reported that phagocytic function of neutrophils was significantly improved by 3-mo BCAA supplementation. In addition, the changes of NK activity were also significant at 3 mo of supplementation compared with before supplementation. Also, Fisher's ratios were reported to be significantly increased at 3 mo of BCAA supplementation compared with those before oral supplementation. Therefore, administration of BCAA could reduce the risk of bacterial and viral infection in patients with decompensated cirrhosis by restoring impaired innate immune responses of the host. In addition, it was also revealed that BCAA oral supplementation could reduce the risk of development of hepatocellular carcinoma in cirrhotic patients. The mechanisms of the effects will also be discussed in this review article.

Keywords: Branched-chain amino acids; Innate immunity; Liver cirrhosis; Natural killer cell activity of lymphocytes; Phagocytic function of neutrophils.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Administration, Oral
  • Amino Acids, Branched-Chain / administration & dosage
  • Amino Acids, Branched-Chain / therapeutic use*
  • Carcinoma, Hepatocellular / immunology
  • Carcinoma, Hepatocellular / prevention & control
  • Dietary Supplements*
  • Humans
  • Immunity, Innate / drug effects*
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / diagnosis
  • Liver Cirrhosis / drug therapy*
  • Liver Cirrhosis / immunology
  • Liver Neoplasms / immunology
  • Liver Neoplasms / prevention & control
  • Neutrophils / drug effects
  • Neutrophils / immunology
  • Phagocytosis / drug effects
  • Risk Factors
  • Treatment Outcome

Substances

  • Amino Acids, Branched-Chain